{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:57:44Z","timestamp":1791183464267,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T00:00:00Z","timestamp":1268956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/cdd.2010.25","type":"journal-article","created":{"date-parts":[[2010,3,19]],"date-time":"2010-03-19T10:09:44Z","timestamp":1268993384000},"page":"1381-1391","source":"Crossref","is-referenced-by-count":62,"title":["Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"M W","family":"Harr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P F","family":"Caimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S N","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W","family":"Distelhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,19]]},"reference":[{"key":"BFcdd201025_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/978-1-4615-4811-9_66","volume":"457","author":"PS Gaynon","year":"1999","unstructured":"Gaynon PS, Carrel AL . Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol 1999; 457: 593\u2013605.","journal-title":"Adv Exp Med Biol"},{"key":"BFcdd201025_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/978-1-4615-4811-9_67","volume":"457","author":"LA Smets","year":"1999","unstructured":"Smets LA, Salomons G, van den Berg J . Glucocorticoid induced apoptosis in leukemia. Adv Exp Med Biol 1999; 457: 607\u2013614.","journal-title":"Adv Exp Med Biol"},{"key":"BFcdd201025_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180000165","volume":"114","author":"R Kofler","year":"2000","unstructured":"Kofler R . The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem Cell Biol 2000; 114: 1\u20137.","journal-title":"Histochem Cell Biol"},{"key":"BFcdd201025_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM . Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006; 63: 60\u201372.","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 1","key":"BFcdd201025_CR5","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R . Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11 (Suppl 1): S45\u2013S55.","journal-title":"Cell Death Differ"},{"key":"BFcdd201025_CR6","first-page":"457","volume":"51","author":"JA Cidlowski","year":"1996","unstructured":"Cidlowski JA, King KL, Evans-Storms RB, Montague JW, Bortner CD, Hughes Jr FM . The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog Horm Res 1996; 51: 457\u2013490; discussion 490\u20131.","journal-title":"Recent Prog Horm Res"},{"key":"BFcdd201025_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1513\/pats.200402-005MS","volume":"1","author":"BM Necela","year":"2004","unstructured":"Necela BM, Cidlowski JA . Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 2004; 1: 239\u2013246.","journal-title":"Proc Am Thorac Soc"},{"key":"BFcdd201025_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","volume":"9","author":"CW Distelhorst","year":"2002","unstructured":"Distelhorst CW . Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6\u201319.","journal-title":"Cell Death Differ"},{"key":"BFcdd201025_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000026368","volume":"6","author":"E Tolosa","year":"1999","unstructured":"Tolosa E, Ashwell JD . Thymus-derived glucocorticoids and the regulation of antigen-specific T-cell development. Neuroimmunomodulation 1999; 6: 90\u201396.","journal-title":"Neuroimmunomodulation"},{"key":"BFcdd201025_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/eji.1830210316","volume":"21","author":"M Iwata","year":"1991","unstructured":"Iwata M, Hanaoka S, Sato K . Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor\/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol 1991; 21: 643\u2013648.","journal-title":"Eur J Immunol"},{"key":"BFcdd201025_CR11","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1073\/pnas.97.13.7319","volume":"97","author":"CA Jamieson","year":"2000","unstructured":"Jamieson CA, Yamamoto KR . Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc Natl Acad Sci USA 2000; 97: 7319\u20137324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201025_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1172\/JCI200418975","volume":"113","author":"DC Tsitoura","year":"2004","unstructured":"Tsitoura DC, Rothman PB . Enhancement of MEK\/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J Clin Invest 2004; 113: 619\u2013627.","journal-title":"J Clin Invest"},{"key":"BFcdd201025_CR13","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","volume":"23","author":"EH Palacios","year":"2004","unstructured":"Palacios EH, Weiss A . Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004; 23: 7990\u20138000.","journal-title":"Oncogene"},{"key":"BFcdd201025_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj20021637","volume":"371","author":"T Mustelin","year":"2003","unstructured":"Mustelin T, Tasken K . Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 2003; 371: 15\u201327.","journal-title":"Biochem J"},{"key":"BFcdd201025_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.immunol.19.1.497","volume":"19","author":"RS Lewis","year":"2001","unstructured":"Lewis RS . Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 2001; 19: 497\u2013521.","journal-title":"Annu Rev Immunol"},{"key":"BFcdd201025_CR16","doi-asserted-by":"publisher","first-page":"31860","DOI":"10.1074\/jbc.M109.005579","volume":"284","author":"MW Harr","year":"2009","unstructured":"Harr MW, Rong Y, Bootman MD, Roderick HL, Distelhorst CW . Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem 2009; 284: 31860\u201331871.","journal-title":"J Biol Chem"},{"key":"BFcdd201025_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0092-8674(00)80571-1","volume":"96","author":"GR Crabtree","year":"1999","unstructured":"Crabtree GR . Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 1999; 96: 611\u2013614.","journal-title":"Cell"},{"key":"BFcdd201025_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/stem.140632","volume":"14","author":"M Iwata","year":"1996","unstructured":"Iwata M, Ohoka Y, Kuwata T, Asada A . Regulation of T cell apoptosis via T cell receptors and steroid receptors. Stem Cells 1996; 14: 632\u2013641.","journal-title":"Stem Cells"},{"key":"BFcdd201025_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1084\/jem.193.7.803","volume":"193","author":"F Van Laethem","year":"2001","unstructured":"Van Laethem F, Baus E, Smyth LA, Andris F, Bex F, Urbain J et al. Glucocorticoids attenuate T cell receptor signaling. J Exp Med 2001; 193: 803\u2013814.","journal-title":"J Exp Med"},{"key":"BFcdd201025_CR20","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.156.12.4555","volume":"156","author":"E Baus","year":"1996","unstructured":"Baus E, Andris F, Dubois PM, Urbain J, Leo O . Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol 1996; 156: 4555\u20134561.","journal-title":"J Immunol"},{"key":"BFcdd201025_CR21","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.175.5.1235","volume":"175","author":"JP Northrop","year":"1992","unstructured":"Northrop JP, Crabtree GR, Mattila PS . Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med 1992; 175: 1235\u20131245.","journal-title":"J Exp Med"},{"key":"BFcdd201025_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2004-12-4790","volume":"106","author":"M Lowenberg","year":"2005","unstructured":"Lowenberg M, Tuynman J, Bilderbeek J, Gaber T, Buttgereit F, van Deventer S et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005; 106: 1703\u20131710.","journal-title":"Blood"},{"key":"BFcdd201025_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/sj.embor.7400775","volume":"7","author":"M Lowenberg","year":"2006","unstructured":"Lowenberg M, Verhaar AP, Bilderbeek J, Marle J, Buttgereit F, Peppelenbosch MP et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep 2006; 7: 1023\u20131029.","journal-title":"EMBO Rep"},{"key":"BFcdd201025_CR24","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1073\/pnas.88.9.3977","volume":"88","author":"KM Abraham","year":"1991","unstructured":"Abraham KM, Levin SD, Marth JD, Forbush KA, Perlmutter RM . Thymic tumorigenesis induced by overexpression of p56lck. Proc Natl Acad Sci USA 1991; 88: 3977\u20133981.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201025_CR25","first-page":"528","volume":"5","author":"M Jucker","year":"1991","unstructured":"Jucker M, Abts H, Eick D, Lenoir GM, Tesch H . Over-expression of lck in Burkitt's lymphoma cell lines. Leukemia 1991; 5: 528\u2013530.","journal-title":"Leukemia"},{"key":"BFcdd201025_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/10428199709050891","volume":"26","author":"A Von Knethen","year":"1997","unstructured":"Von Knethen A, Abts H, Kube D, Diehl V, Tesch H . Expression of p56lck in B-cell neoplasias. Leuk Lymphoma 1997; 26: 551\u2013562.","journal-title":"Leuk Lymphoma"},{"key":"BFcdd201025_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0145-2126(91)90103-Z","volume":"15","author":"H Abts","year":"1991","unstructured":"Abts H, Jucker M, Diehl V, Tesch H . Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. Leuk Res 1991; 15: 987\u2013997.","journal-title":"Leuk Res"},{"key":"BFcdd201025_CR28","first-page":"246","volume":"7","author":"E Rouer","year":"1993","unstructured":"Rouer E, Dreyfus F, Melle J, Ribrag V, Benarous R . Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignancies. Leukemia 1993; 7: 246\u2013250.","journal-title":"Leukemia"},{"key":"BFcdd201025_CR29","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V91.9.3390.3390_3390_3396","volume":"91","author":"MB Majolini","year":"1998","unstructured":"Majolini MB, D'Elios MM, Galieni P, Boncristiano M, Lauria F, Del Prete G et al. Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells. Blood 1998; 91: 3390\u20133396.","journal-title":"Blood"},{"key":"BFcdd201025_CR30","doi-asserted-by":"publisher","first-page":"12498","DOI":"10.1073\/pnas.95.21.12498","volume":"95","author":"BK al-Ramadi","year":"1998","unstructured":"al-Ramadi BK, Zhang H, Bothwell AL . Cell-cycle arrest and apoptosis hypersusceptibility as a consequence of Lck deficiency in nontransformed T lymphocytes. Proc Natl Acad Sci USA 1998; 95: 12498\u201312503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd201025_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/sj.onc.1209218","volume":"25","author":"Z Wang","year":"2006","unstructured":"Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, Distelhorst CW . Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 2006; 25: 1903\u20131913.","journal-title":"Oncogene"},{"key":"BFcdd201025_CR32","doi-asserted-by":"publisher","first-page":"23861","DOI":"10.1074\/jbc.M301843200","volume":"278","author":"Z Wang","year":"2003","unstructured":"Wang Z, Malone MH, He H, McColl KS, Distelhorst CW . Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003; 278: 23861\u201323867.","journal-title":"J Biol Chem"},{"key":"BFcdd201025_CR33","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","volume":"111","author":"AE Schade","year":"2008","unstructured":"Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R et al. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood 2008; 111: 1366\u20131377.","journal-title":"Blood"},{"key":"BFcdd201025_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/leu.2008.322","volume":"23","author":"S Faderl","year":"2009","unstructured":"Faderl S, Ferrajoli A, Frankfurt O, Pettitt A . Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy. Leukemia 2009; 23: 457\u2013466.","journal-title":"Leukemia"},{"key":"BFcdd201025_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.autrev.2007.02.021","volume":"7","author":"DG Efremov","year":"2007","unstructured":"Efremov DG, Gobessi S, Longo PG . Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmun Rev 2007; 7: 102\u2013108.","journal-title":"Autoimmun Rev"},{"key":"BFcdd201025_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1172\/JCI200522094","volume":"115","author":"A Contri","year":"2005","unstructured":"Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L et al. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 2005; 115: 369\u2013378.","journal-title":"J Clin Invest"},{"key":"BFcdd201025_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/362087a0","volume":"362","author":"MJ Eck","year":"1993","unstructured":"Eck MJ, Shoelson SE, Harrison SC . Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature 1993; 362: 87\u201391.","journal-title":"Nature"},{"key":"BFcdd201025_CR38","doi-asserted-by":"publisher","first-page":"16746","DOI":"10.1021\/bi9620868","volume":"35","author":"RC Cousins-Wasti","year":"1996","unstructured":"Cousins-Wasti RC, Ingraham RH, Morelock MM, Grygon CA . Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity. Biochemistry 1996; 35: 16746\u201316752.","journal-title":"Biochemistry"},{"key":"BFcdd201025_CR39","doi-asserted-by":"publisher","first-page":"24880","DOI":"10.1074\/jbc.271.40.24880","volume":"271","author":"C Couture","year":"1996","unstructured":"Couture C, Songyang Z, Jascur T, Williams S, Tailor P, Cantley LC et al. Regulation of the Lck SH2 domain by tyrosine phosphorylation. J Biol Chem 1996; 271: 24880\u201324884.","journal-title":"J Biol Chem"},{"key":"BFcdd201025_CR40","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/MCB.12.6.2720","volume":"12","author":"L Caron","year":"1992","unstructured":"Caron L, Abraham N, Pawson T, Veillette A . Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Mol Cell Biol 1992; 12: 2720\u20132729.","journal-title":"Mol Cell Biol"},{"key":"BFcdd201025_CR41","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","volume":"68","author":"F Hilberg","year":"2008","unstructured":"Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res 2008; 68: 4774\u20134782.","journal-title":"Cancer Res"},{"key":"BFcdd201025_CR42","first-page":"3785","volume":"37","author":"MR Norman","year":"1977","unstructured":"Norman MR, Thompson EB . Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res 1977; 37: 3785\u20133791.","journal-title":"Cancer Res"},{"key":"BFcdd201025_CR43","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1182\/blood-2006-11-056366","volume":"109","author":"WJ Tissing","year":"2007","unstructured":"Tissing WJ, den Boer ML, Meijerink JP, Menezes RX, Swagemakers S, van der Spek PJ et al. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Blood 2007; 109: 3929\u20133935.","journal-title":"Blood"},{"key":"BFcdd201025_CR44","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2005-07-2853","volume":"107","author":"S Schmidt","year":"2006","unstructured":"Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmuller C et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006; 107: 2061\u20132069.","journal-title":"Blood"},{"key":"BFcdd201025_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.191.3.463","volume":"191","author":"T Sosinowski","year":"2000","unstructured":"Sosinowski T, Pandey A, Dixit VM, Weiss A . Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J Exp Med 2000; 191: 463\u2013474.","journal-title":"J Exp Med"},{"key":"BFcdd201025_CR46","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.leukres.2009.06.029","volume":"34","author":"M Mansha","year":"2009","unstructured":"Mansha M, Carlet M, Ploner C, Gruber G, Wasim M, Wiegers GJ et al. Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia. Leuk Res 2009; 34: 529\u2013534.","journal-title":"Leuk Res"},{"key":"BFcdd201025_CR47","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/leu.2009.80","volume":"23","author":"AA Rambal","year":"2009","unstructured":"Rambal AA, Panaguiton ZL, Kramer L, Grant S, Harada H . MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Leukemia 2009; 23: 1744\u20131754.","journal-title":"Leukemia"},{"key":"BFcdd201025_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2141.2008.07418.x","volume":"143","author":"L Amrein","year":"2008","unstructured":"Amrein L, Hernandez TA, Ferrario C, Johnston J, Gibson SB, Panasci L et al. Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. Br J Haematol 2008; 143: 698\u2013706.","journal-title":"Br J Haematol"},{"key":"BFcdd201025_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beha.2007.04.001","volume":"20","author":"TJ Kipps","year":"2007","unstructured":"Kipps TJ . The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007; 20: 415\u2013424.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFcdd201025_CR50","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2007-11-123984","volume":"112","author":"A Veldurthy","year":"2008","unstructured":"Veldurthy A, Patz M, Hagist S, Pallasch CP, Wendtner CM, Hallek M et al. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. Blood 2008; 112: 1443\u20131452.","journal-title":"Blood"},{"key":"BFcdd201025_CR51","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.bmc.2003.10.060","volume":"12","author":"NH Nam","year":"2004","unstructured":"Nam NH, Pitts RL, Sun G, Sardari S, Tiemo A, Xie M et al. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorg Med Chem 2004; 12: 779\u2013787.","journal-title":"Bioorg Med Chem"},{"key":"BFcdd201025_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3324\/haematol.11903","volume":"93","author":"M Dungarwalla","year":"2008","unstructured":"Dungarwalla M, Evans SO, Riley U, Catovsky D, Dearden CE, Matutes E . High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. Haematologica 2008; 93: 475\u2013476.","journal-title":"Haematologica"},{"key":"BFcdd201025_CR53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V80.4.887.887","volume":"80","author":"R Alexanian","year":"1992","unstructured":"Alexanian R, Dimopoulos MA, Delasalle K, Barlogie B . Primary dexamethasone treatment of multiple myeloma. Blood 1992; 80: 887\u2013890.","journal-title":"Blood"},{"key":"BFcdd201025_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1083\/jcb.200506189","volume":"172","author":"F Zhong","year":"2006","unstructured":"Zhong F, Davis MC, McColl KS, Distelhorst CW . Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation. J Cell Biol 2006; 172: 127\u2013137.","journal-title":"J Cell Biol"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd201025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201025","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd201025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T03:04:01Z","timestamp":1685502241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd201025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,19]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["BFcdd201025"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2010.25","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,19]]}}}